SRTA
Strata Critical Medical, Inc.
5.30$
+1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +11.4% | +13.3% | +860.6% | +24.2% | -16.2% | +37.3% | |
| – | +54.6% | +1,863.5% | -14.0% | +51.0% | +59.1% | -10.4% | |
| – | – | – | – | – | – | – | |
| – | -55.9% | -21.2% | +145.8% | +188.9% | +1,464.4% | -66.6% | |
| – | -64.2% | +85,135.5% | – | -78.5% | -105.9% | – | |
| – | – | – | – | – | – | -100.0% | |
| – | – | – | -100.0% | – | – | – | |
| – | +917.2% | +28,057.5% | -100.3% | -93.0% | +7,477.6% | +54.7% | |
| – | – | – | – | -141.8% | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.